Disease Information | ||||||
---|---|---|---|---|---|---|
Disease Name | Gene Name | Type | UMLS | Association Type | Score | Source |
Neurotoxicity Syndrome | BCL2L1 | group | C0235032 | Biomarker | 0.3 | disgenet |
Neurotoxicity Syndrome | ADRA1B | group | C0235032 | Biomarker | 0.3 | disgenet |
Neurotoxicity Syndrome | MTOR | group | C0235032 | Biomarker | 0.3 | disgenet |
Neurotoxicity Syndrome | NQO1 | group | C0235032 | Therapeutic | 0.3 | disgenet |
Neurotoxicity Syndrome | TIMP3 | group | C0235032 | Biomarker | 0.3 | disgenet |
Neurotoxicity Syndrome | CASP3 | group | C0235032 | Biomarker | 0.3 | disgenet |
Neurotoxicity Syndrome | CRISPLD2 | group | C0235032 | Biomarker | 0.3 | disgenet |
Neurotoxicity Syndrome | ST8SIA1 | group | C0235032 | Biomarker | 0.3 | disgenet |
Neurotoxicity Syndrome | ALOX5AP | group | C0235032 | Biomarker | 0.3 | disgenet |
Neurotoxicity Syndrome | BCHE | group | C0235032 | Therapeutic | 0.3 | disgenet |
Neurotoxicity Syndrome | CD3D | group | C0235032 | Biomarker | 0.3 | disgenet |
Neurotoxicity Syndrome | CYP3A5 | group | C0235032 | Therapeutic | 0.3 | disgenet |
Neurotoxicity Syndrome | RNASE6 | group | C0235032 | Biomarker | 0.3 | disgenet |
Neurotoxicity Syndrome | ABCB1 | group | C0235032 | Biomarker | 0.3 | disgenet |
Neurotoxicity Syndrome | PRKCD | group | C0235032 | Biomarker | 0.3 | disgenet |
Neurotoxicity Syndrome | PLAT | group | C0235032 | Biomarker | 0.3 | disgenet |
Neurotoxicity Syndrome | NFE2L2 | group | C0235032 | Therapeutic | 0.3 | disgenet |
Neurotoxicity Syndrome | PON1 | group | C0235032 | Therapeutic | 0.3 | disgenet |
Neurotoxicity Syndrome | FOS | group | C0235032 | Therapeutic | 0.3 | disgenet |
Neurotoxicity Syndrome | ADCYAP1 | group | C0235032 | Therapeutic | 0.3 | disgenet |
Neurotoxicity Syndrome | P2RX1 | group | C0235032 | Biomarker | 0.3 | disgenet |
Neurotoxicity Syndrome | CCK | group | C0235032 | Biomarker | 0.3 | disgenet |
Neurotoxicity Syndrome | GABRR2 | group | C0235032 | Biomarker | 0.3 | disgenet |
Neurotoxicity Syndrome | ADD3 | group | C0235032 | Biomarker | 0.3 | disgenet |
Neurotoxicity Syndrome | SRSF5 | group | C0235032 | Biomarker | 0.3 | disgenet |
Neurotoxicity Syndrome | EGLN1 | group | C0235032 | Biomarker | 0.3 | disgenet |
Neurotoxicity Syndrome | PTGES3 | group | C0235032 | Biomarker | 0.3 | disgenet |
Neurotoxicity Syndrome | TGM1 | group | C0235032 | Biomarker | 0.3 | disgenet |
Neurotoxicity Syndrome | LAT | group | C0235032 | Biomarker | 0.3 | disgenet |
Neurotoxicity Syndrome | SLC18A2 | group | C0235032 | Biomarker | 0.2 | disgenet |
Neurotoxicity Syndrome | DRD2 | group | C0235032 | Biomarker | 0.2 | disgenet |
Neurotoxicity Syndrome | EPHA4 | group | C0235032 | Biomarker | 0.2 | disgenet |
Neurotoxicity Syndrome | IL10 | group | C0235032 | Therapeutic | 0.2 | disgenet |
Neurotoxicity Syndrome | CAT | group | C0235032 | Biomarker | 0.2 | disgenet |
click here to return to the previous page |